Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3500 participants
OBSERVATIONAL
2021-05-01
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
China Health Big Data
NCT03699228
A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults
NCT05455099
The Relationship Between Blood Pressure and Arterial Stiffness in HFpEF Patients With Different Levels of Obesity
NCT04535726
Fatty Liver Disease Collaborative Research in China
NCT02391168
The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients
NCT04594499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To detect the smallest difference between adjacent age groups within the age range 18-79 (6 groups, α = 0.05, β = 0.20, Statistical Power = 0.80). Given the influence of multiple centers, the minimum sample size is 1800, the optimal sample size is 3500. The male to female ratio is 1:1.
Quality Control including the pre-study training and data monitoring during the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The blood pressure is normal: systolic blood pressure \<140 mmHg, and diastolic blood pressure \<90 mmHg
* The physical examination and electrocardiogram are normal
Exclusion Criteria
* Subjects with previous cardiovascular disease history and medication history should be excluded. The main diseases include coronary heart disease, congenital heart disease, heart failure, hypertension, stroke, hyperlipidemia, diabetes, aortic arteritis, etc.;
* Subjects with past medical history and medication history of endocrine, rheumatism, chronic respiratory disease, liver and kidney disease should be excluded;
* Obese subjects (BMI ≥ 28 kg/m2), professional athletes, pregnant and lactating women should be excluded;
* Alcohol or drug addicts and smokers who have not quit smoking should be excluded.
18 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Esaote (Shenzhen) Medical Equipment Co. Ltd
UNKNOWN
Zhejiang University
OTHER
Shannxi Provincial People's Hospital
UNKNOWN
Shengjing Hospital
OTHER
First Hospital of China Medical University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Renmin Hospital of Wuhan University
OTHER
Beijing University of Chinese Medicine Third Affiliated Hospital
UNKNOWN
The First Affiliated Hospital of Shanxi Medical University
OTHER
The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology
UNKNOWN
The First Hospital of Jilin University
OTHER
The Afffiliated Hospital of Guizhou Medical University
UNKNOWN
Yan An Hospital Affiliated to Kunming Medical University
UNKNOWN
Second Affiliated Hospital of Guangzhou Medical University
OTHER
Third Xiangya Hospital of Central South University
UNKNOWN
Ruijin Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
The First Affiliated Hospital of Anhui Medical University
OTHER
The Second Hospital of Anhui Medical University
OTHER
The First Affiliated Hospital of USTC
UNKNOWN
The Affiliated Hospital of Qingdao University
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
Hospital of Northwestern Polytechnical University
UNKNOWN
GEM Flower Xian Changqing Staff Hospital
UNKNOWN
Xi'an Central Hospital
OTHER
Second Affiliated Hospital of Xi'an Jiaotong University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Karamay Central Hospital of Xinjiang
UNKNOWN
Fourth Affiliated Hospital of Xinjiang Medical University
OTHER
Xi'an No.1 Hospital
UNKNOWN
Xianyang Hospital of Yan'an University
UNKNOWN
General Hospital of Xinjiang Production and Construction Corps
UNKNOWN
Air Force Military Medical University, China
OTHER
Tang-Du Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lijun Yuan, MD, PhD
Director of the department of ultrasound diagnostics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lijun Yuan, PhD; MD
Role: PRINCIPAL_INVESTIGATOR
Tangdu Hospital-Air Force Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
The First Affiliated Hospital of USTC
Hefei, Anhui, China
The Second Hospital of Anhui Medical University
Hefei, Anhui, China
Air Force Medical Center
Beijing, Beijing Municipality, China
Beijing University of Chinese Medicine Third Affiliated Hospital
Beijing, Beijing Municipality, China
Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
The Afffiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
Third Xiangya Hospital of Central South University
Changsha, Hunan, China
The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology
Baotou, Inner Mongolia, China
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China
The First Hospital of Jilin University
Changchun, Jilin, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
First Hospital of China Medical University
Shenyang, Liaoning, China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Ruijin Hospital
Shanghai, Shanghai Municipality, China
Tangdu Hospital, Air Force Medical University
Xi'an, Shannxi, China
Shannxi Provincial People's Hospital
Xi'an, Shannxi, China
GEM Flower Xian Changqing Staff Hospital
Xi'an, Shannxi, China
Hospital of Northwestern Polytechnical University
Xi'an, Shannxi, China
Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shannxi, China
The Second Affiliated Hospital of Xi'an Medical University
Xi'an, Shannxi, China
Xi'an Central Hospital
Xi'an, Shannxi, China
Xi'an No.1 Hospital
Xi'an, Shannxi, China
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Xianyang Hospital of Yan'an University
Xianyang, Shanxi, China
General Hospital of Xinjiang Production and Construction Corps
Ürümqi, Xijiang, China
Karamay Central Hospital of Xinjiang
Karamay, Xinjiang, China
First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
The Fourth Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
Yan An Hospital Affiliated to Kunming Medical University
Kunming, Yunnan, China
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xianyue Yang
Role: primary
Shuqing Jiang
Role: primary
Jun Wu
Role: primary
Bin Ma
Role: primary
Jingfang Dong
Role: primary
Lin Mao
Role: primary
Qiao Que
Role: primary
Bei Zhang
Role: primary
Juhong Pan
Role: primary
Yu Wu
Role: primary
Wenhui Zhu
Role: primary
Shiji Wang
Role: primary
Jianxiang Wang
Role: primary
Na Su
Role: primary
Xiaona Yu
Role: primary
Huangliang Liu
Role: primary
Yongmei Sun
Role: primary
Ri Ji
Role: primary
Changyang Xing
Role: primary
Aihua Wei
Role: primary
Hao Wang
Role: primary
Fan Li
Role: primary
Ting Liu
Role: primary
Hengli Yang
Role: primary
Xue Dong
Role: primary
Xiaojun Zhan
Role: primary
Qianjun Ye
Role: primary
Bei Jia
Role: primary
Ying Zhuang
Role: primary
Erke Zhang
Role: primary
Ting Ma
Role: primary
Zhanlei Chen
Role: primary
Xuan Su
Role: primary
Xiujing Xie
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20210402V2.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.